The 340B Tug-of-War: Hospitals and Regulators Clash Over Revived Rebate Pilot on October 13, 2026 Posted by
Beyond the V-Taper: The Comprehensive Guide to Latissimus Dorsi Development on October 13, 2026 Posted by
The Shifting Landscape at NIAID: Steven Quay’s Evolving Role in Federal Health Policy on October 13, 2026 Posted by
The Critical Role of Respiratory Effort Belts in Modern Sleep Diagnostics: A Comprehensive Industry Guide on October 13, 2026 Posted by
Advancing the Standard of Care: Dr. Ball Achieves Medidata Certification to Revolutionize Pain Management on October 13, 2026 Posted by
The Immune Paradox: Unlocking the Biological Secrets of Chronic Diabetic Ulcers on October 13, 2026 Posted by
Conflicting Messages: An Analysis of the 2025–2030 Dietary Guidelines for Americans on October 13, 2026 Posted by
The 340B Tug-of-War: Hospitals and Regulators Clash Over Revived Rebate Pilot on October 13, 2026 Posted by
Beyond the V-Taper: The Comprehensive Guide to Latissimus Dorsi Development on October 13, 2026 Posted by
The Shifting Landscape at NIAID: Steven Quay’s Evolving Role in Federal Health Policy on October 13, 2026 Posted by
The Critical Role of Respiratory Effort Belts in Modern Sleep Diagnostics: A Comprehensive Industry Guide on October 13, 2026 Posted by
Posted in Sleep Health Advancing Neuroscience: Alkermes Opens 9th Annual Pathways Research Awards with Expanded Focus on Sleep Medicine on September 23, 2026
Posted in Medical Innovations Pharma Pulse: Novo Nordisk’s Consumer-Centric Pivot and Alkermes’ ADHD Breakthrough on September 21, 2026
Posted in Digital Health Tools Beyond Narcolepsy: Alkermes Unveils Potential ADHD Breakthrough with Orexin Agonists on September 21, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Extension Study on August 10, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Study on August 2, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Alkermes’ Alixorexton Shows Sustained Efficacy in Long-Term Clinical Study on July 25, 2026
Posted in Medical Innovations The Orexin Frontier: How Alkermes Is Positioning Its "Alixorexton" to Disrupt the Sleep Medicine Landscape on June 27, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Trial on June 2, 2026 rifanmuazin
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Study on May 22, 2026 rifanmuazin
